Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) reported topline Phase 3 results for their LP.8.1-adapted monovalent COMIRNATY (2025-2026 Formula) in high-risk adults. Among 100 participants, the ...
Hosted on MSN
FTC Reports Sharp Rise in Senior Impersonation Scams
WASHINGTON — New Federal Trade Commission data reveals a more than four-fold increase since 2020 in reports from adults 60 and older who lost $10,000 or more to impersonation scams, with combined ...
Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback